BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 29089434)

  • 1. Erratum for Sivan et al., "Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L
    Sivan G; Ormanoglu P; Buehler EC; Martin SE; Moss B
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089434
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant.
    Sivan G; Ormanoglu P; Buehler EC; Martin SE; Moss B
    mBio; 2015 Aug; 6(4):e01122. PubMed ID: 26242627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation Inhibition.
    Sivan G; Glushakow-Smith SG; Katsafanas GC; Americo JL; Moss B
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia virus host range genes.
    Perkus ME; Goebel SJ; Davis SW; Johnson GP; Limbach K; Norton EK; Paoletti E
    Virology; 1990 Nov; 179(1):276-86. PubMed ID: 2171207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of a protein encoded by the vaccinia virus C7L open reading frame and study of its effect on virus multiplication in different cell lines.
    Oguiura N; Spehner D; Drillien R
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1409-13. PubMed ID: 8336123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-replicating Vaccinia Virus TianTan Strain (NTV) Translation Arrest of Viral Late Protein Synthesis Associated With Anti-viral Host Factor SAMD9.
    Zhao Y; Zhao L; Huang P; Ren J; Zhang P; Tian H; Tan W
    Front Cell Infect Microbiol; 2020; 10():116. PubMed ID: 32266167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
    Ramsey-Ewing AL; Moss B
    Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A paralogous pair of mammalian host restriction factors form a critical host barrier against poxvirus infection.
    Meng X; Zhang F; Yan B; Si C; Honda H; Nagamachi A; Sun LZ; Xiang Y
    PLoS Pathog; 2018 Feb; 14(2):e1006884. PubMed ID: 29447249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo study of the ectromelia virus homolog of the vaccinia virus K1L host range gene.
    Chen W; Drillien R; Spehner D; Buller RM
    Virology; 1993 Oct; 196(2):682-93. PubMed ID: 8372441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences.
    Smith KA; Stallard V; Roos JM; Hart C; Cormier N; Cohen LK; Roberts BE; Payne LG
    Vaccine; 1993; 11(1):43-53. PubMed ID: 8427036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins.
    Meng X; Krumm B; Li Y; Deng J; Xiang Y
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14858-63. PubMed ID: 26578811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
    Backes S; Sperling KM; Zwilling J; Gasteiger G; Ludwig H; Kremmer E; Schwantes A; Staib C; Sutter G
    J Gen Virol; 2010 Feb; 91(Pt 2):470-82. PubMed ID: 19846675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein.
    Bradley RR; Terajima M
    Virus Res; 2005 Dec; 114(1-2):104-12. PubMed ID: 16039000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.
    Shisler JL; Jin XL
    J Virol; 2004 Apr; 78(7):3553-60. PubMed ID: 15016878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and host restriction of vaccinia virus in RK13 cells.
    Chung CS; Vasilevskaya IA; Wang SC; Bair CH; Chang W
    Virus Res; 1997 Dec; 52(2):121-32. PubMed ID: 9495528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress in the structure and fuction of Orthopoxvirus host range genes].
    Liu Z; Liu Y; Shao YM
    Bing Du Xue Bao; 2013 Jun; 29(4):437-41. PubMed ID: 23895011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
    Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
    Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NYVAC: a highly attenuated strain of vaccinia virus.
    Tartaglia J; Perkus ME; Taylor J; Norton EK; Audonnet JC; Cox WI; Davis SW; van der Hoeven J; Meignier B; Riviere M
    Virology; 1992 May; 188(1):217-32. PubMed ID: 1566575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
    Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
    Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient host range selection for genetic engineering of modified vaccinia virus Ankara.
    Staib C; Drexler I; Ohlmann M; Wintersperger S; Erfle V; Sutter G
    Biotechniques; 2000 Jun; 28(6):1137-42, 1144-6, 1148. PubMed ID: 10868279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.